- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prediction and clinical utility of a contralateral breast cancer risk model ; volume:21 ; number:1 ; day:17 ; month:12 ; year:2019 ; pages:1-13 ; date:12.2019
Breast cancer research ; 21, Heft 1 (17.12.2019), 1-13, 12.2019
- Creator
-
Giardiello, Daniele
Steyerberg, Ewout W.
Hauptmann, Michael
Adank, Muriel A.
Akdeniz, Delal
Blomqvist, Carl
Bojesen, Stig E.
Bolla, Manjeet K.
Brinkhuis, Mariël
Chang-Claude, Jenny
Czene, Kamila
Devilee, Peter
Dunning, Alison M.
Easton, Douglas F.
Eccles, Diana M.
Fasching, Peter Andreas
Figueroa, Jonine
Flyger, Henrik
García-Closas, Montserrat
Haeberle, Lothar
Haiman, Christopher A.
Hall, Per
Hamann, Ute
Hopper, John L.
Jager, Agnes
Jakubowska, Anna
Jung, Audrey
Keeman, Renske
Kramer, Iris
Lambrechts, Diether
Marchand, Loic Le
Lindblom, Annika
Lubiński, Jan
Manoochehri, Mehdi
Mariani, Luigi
Nevanlinna, Heli
Oldenburg, Hester S. A.
Pelders, Saskia
Pharoah, Paul D. P.
Shah, Mitul
Siesling, Sabine
Smit, Vincent T. H. B. M.
Southey, Melissa C.
Tapper, William J.
Tollenaar, Rob A. E. M.
Broek, Alexandra J. van den
Deurzen, Carolien H. M. van
Leeuwen, Flora E. van
Ongeval, Chantal van
Van’t Veer, Laura J.
Wang, Qin
Wendt, Camilla
Westenend, Pieter J.
Hooning, Maartje J.
Schmidt, Marjanka K.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-019-1221-1
- URN
-
urn:nbn:de:101:1-2020040800074500729467
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Giardiello, Daniele
- Steyerberg, Ewout W.
- Hauptmann, Michael
- Adank, Muriel A.
- Akdeniz, Delal
- Blomqvist, Carl
- Bojesen, Stig E.
- Bolla, Manjeet K.
- Brinkhuis, Mariël
- Chang-Claude, Jenny
- Czene, Kamila
- Devilee, Peter
- Dunning, Alison M.
- Easton, Douglas F.
- Eccles, Diana M.
- Fasching, Peter Andreas
- Figueroa, Jonine
- Flyger, Henrik
- García-Closas, Montserrat
- Haeberle, Lothar
- Haiman, Christopher A.
- Hall, Per
- Hamann, Ute
- Hopper, John L.
- Jager, Agnes
- Jakubowska, Anna
- Jung, Audrey
- Keeman, Renske
- Kramer, Iris
- Lambrechts, Diether
- Marchand, Loic Le
- Lindblom, Annika
- Lubiński, Jan
- Manoochehri, Mehdi
- Mariani, Luigi
- Nevanlinna, Heli
- Oldenburg, Hester S. A.
- Pelders, Saskia
- Pharoah, Paul D. P.
- Shah, Mitul
- Siesling, Sabine
- Smit, Vincent T. H. B. M.
- Southey, Melissa C.
- Tapper, William J.
- Tollenaar, Rob A. E. M.
- Broek, Alexandra J. van den
- Deurzen, Carolien H. M. van
- Leeuwen, Flora E. van
- Ongeval, Chantal van
- Van’t Veer, Laura J.
- Wang, Qin
- Wendt, Camilla
- Westenend, Pieter J.
- Hooning, Maartje J.
- Schmidt, Marjanka K.
- SpringerLink (Online service)
Other Objects (12)
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer
Unravelling genetic variants of a swedish family with high risk of prostate cancer
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
Breast Cancer Susceptibility—Towards Individualised Risk Prediction
CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~200,000 patients
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in~200,000 patients
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Massive parallel sequencing in a family with rectal cancer
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer
Unravelling genetic variants of a swedish family with high risk of prostate cancer
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
Breast Cancer Susceptibility—Towards Individualised Risk Prediction
CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~200,000 patients
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in~200,000 patients
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Massive parallel sequencing in a family with rectal cancer
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer
Unravelling genetic variants of a swedish family with high risk of prostate cancer
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
Breast Cancer Susceptibility—Towards Individualised Risk Prediction
CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~200,000 patients
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in~200,000 patients
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Massive parallel sequencing in a family with rectal cancer